UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

Neurobiology of disease, 2019-04, Vol.124 (C), p.276-288

2019

Volltextzugriff (PDF)

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells

PloS one, 2021-03, Vol.16 (3), p.e0247701-e0247701

2021

Volltextzugriff (PDF)

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

Arthritis research & therapy, 2015-09, Vol.17 (1), p.234, Article 234

2015

Volltextzugriff (PDF)

334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A383-A383

2023

Volltextzugriff (PDF)

CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma

Oncoimmunology, 2022-12, Vol.11 (1), p.2111904-2111904

2022

Volltextzugriff (PDF)

TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease

The Journal of experimental medicine, 2008-05, Vol.205 (5), p.1049-1062

2008

Volltextzugriff (PDF)

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

Arthritis research & therapy, 2009-01, Vol.11 (5), p.R143-R143

2009

Volltextzugriff (PDF)

Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells

The Journal of biological chemistry, 2009-11, Vol.284 (47), p.32686-32694

2009

Volltextzugriff (PDF)

A Novel Role for Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) in the Development of Cardiac Dysfunction and Failure

Circulation (New York, N.Y.), 2009-04, Vol.119 (15), p.2058-2068

2009

Volltextzugriff (PDF)

TWEAK Is a Novel Arthritogenic Mediator

Journal of Immunology, 2006-08, Vol.177 (4), p.2610-2620

2006

Volltextzugriff (PDF)

Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells

Journal of Immunology, 2006-02, Vol.176 (3), p.1889-1898

2006

Volltextzugriff (PDF)

133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A146-A146

2020

Volltextzugriff (PDF)

PGC1α plays a critical role in TWEAK-induced cardiac dysfunction

PloS one, 2013, Vol.8 (1), p.e54054-e54054

2013

Volltextzugriff (PDF)

TNF-like weak inducer of apoptosis (TWEAK) promotes beta cell neogenesis from pancreatic ductal epithelium in adult mice

PloS one, 2013-08, Vol.8 (8), p.e72132-e72132

2013

Volltextzugriff (PDF)

Urinary TWEAK and the activity of lupus nephritis

Journal of autoimmunity, 2006-12, Vol.27 (4), p.242-250

2006

Volltextzugriff (PDF)

Cutting Edge: BAFF Regulates CD21/35 and CD23 Expression Independent of Its B Cell Survival Function

The Journal of immunology (1950), 2004-01, Vol.172 (2), p.762-766

2004

Volltextzugriff (PDF)

Characterization of Aleta-001, a CAR T Engager Designed to Optimize Responses and Prevent Relapses from CAR-19 Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.1713-1713

2021

Volltextzugriff (PDF)

Development of an Fn14 agonistic antibody as an anti-tumor agent

mAbs, 2011-07, Vol.3 (4), p.362-375

2011

Volltextzugriff (PDF)

A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo

Blood, 2019-11, Vol.134 (Supplement_1), p.252-252

2019

Volltextzugriff (PDF)

Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia In Vitro and In Vivo

Molecular cancer therapeutics, 2021-10, Vol.20 (10), p.2071-2081

2021

Volltextzugriff (PDF)

Abstract B020: CAR-CD19 T cells secreting multi-antigen bridging proteins eliminate solid tumors

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.B020-B020

2019

Volltextzugriff (PDF)

175 CAR-T engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A187-A187

2022

Volltextzugriff (PDF)

Abstract 2569: CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2569-2569

2018

Volltextzugriff (PDF)

Activity of CAR19 T cells secreting impact fusion proteins against hematopoietic and solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15046-e15046

2018

Volltextzugriff (PDF)

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Blood, 2017-12, Vol.130, p.4457-4457

2017

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(186)

Publikationsform

Artikel
(213)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Physical Sciences
(66)
Optics
(46)
Life Sciences & Biomedicine
(34)
Physics
(33)
Technology
(27)
Physics, Applied
(23)
Animals
(22)
Crystals
(19)
Humans
(18)
Lasers
(17)
Materials Science
(15)
Materials Science, Multidisciplinary
(13)
Chemistry
(12)
Exact Sciences And Technology
(11)
Biochemistry & Molecular Biology
(10)
Engineering
(10)
Mice
(10)
Biological And Medical Sciences
(9)
Apoptosis
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors

CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma

TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells

A Novel Role for Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) in the Development of Cardiac Dysfunction and Failure

TWEAK Is a Novel Arthritogenic Mediator

Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells

133 Development of novel cellular therapeutics for metastatic and primary CNS malignancies

PGC1α plays a critical role in TWEAK-induced cardiac dysfunction

TNF-like weak inducer of apoptosis (TWEAK) promotes beta cell neogenesis from pancreatic ductal epithelium in adult mice

Urinary TWEAK and the activity of lupus nephritis

Cutting Edge: BAFF Regulates CD21/35 and CD23 Expression Independent of Its B Cell Survival Function

Characterization of Aleta-001, a CAR T Engager Designed to Optimize Responses and Prevent Relapses from CAR-19 Therapy

Development of an Fn14 agonistic antibody as an anti-tumor agent

A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo

Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia In Vitro and In Vivo

Abstract B020: CAR-CD19 T cells secreting multi-antigen bridging proteins eliminate solid tumors

175 CAR-T engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma

Abstract 2569: CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types

Activity of CAR19 T cells secreting impact fusion proteins against hematopoietic and solid tumors

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Suchergebnisse filtern